Late Sodium Current Blockade in High-Risk ICD Patients
Phase of Trial: Phase III
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Ranolazine (Primary)
- Indications Arrhythmias; Cardiomyopathies; Heart failure
- Focus Therapeutic Use
- Acronyms RAID
- 24 Mar 2017 Status changed from active, no longer recruiting to completed.
- 28 Sep 2016 Planned End Date changed from 1 Feb 2017 to 1 Sep 2017.
- 30 Dec 2015 Planned End Date changed from 1 Oct 2015 to 1 Feb 2017, as reported by ClinicalTrials.gov.